Posted in | News | Gold

Tara Minerals Announces Commencement of Drill Program at Ponderosa Gold Project

Tara Minerals Corp. is pleased to announce that a drill program to define the veins at depth and to map them underground has begun. The short-term priority for the program is to further delineate the exposed veins.

In addition, ongoing exploration work has resulted in the uncovering of new mineralized structures and the discovery of additional historical workings. Assays from the mineralized portions of the structures are consistent with the average 0.5 oz/t gold found in the priority veins.

Mr. Steve Eady, Chief Geologist, stated, "The veins are consistent in gold grade and the gold is recoverable. Now it is a matter of following each of the veins at surface, understanding their shape and geology, and prioritizing them for delineation to gauge tonnage potential. We are in a geologically attractive mining district as shown by the work being carried out by the partnership of Midas Gold Corp., Franco-Nevada Corporation and Teck Resources Limited to the south. We have community and regulatory support for production and are making progress towards this goal."

The Ponderosa Project consists of 6,721 acres of both patented and unpatented mining claims in central Idaho, USA. The optioned claims include previously mined veins with historic sampling of the exposed outcrops averaging 0.5 oz/t gold.

About Tara Minerals Corp.

Tara is currently focused on advancing its US and Mexico project pipeline towards 2013 production. In addition to achieving production, management is creating long-term shareholder value and deploying its capital to advance its projects by enhancing resources, further outlining new discoveries/targets, and acquiring additional strategic assets.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.